ReP USP - Resultado da busca

Artigo de periodico
A BCS-based biowaiver approach using biphasic dissolution test (2021)
Silva, Daniela Amaral; Melo, Katherine Jasmine Curo; Davies, Neal M; Bou-Chacra, Nadia Araci ; Ferraz, Humberto Gomes ; Löbenberg, Raimar
Fonte: Dissolution Technology. Unidade: FCF
Assuntos: BIOEQUIVALÊNCIA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. A BCS-based biowaiver approach using biphasic dissolution test. Dissolution Technology, v. 28, n. 4, p. 40-48, 2021Tradução . . Disponível em: https://doi.org/10.14227/DT280421P40. Acesso em: 04 out. 2024.
APA
Silva, D. A., Melo, K. J. C., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2021). A BCS-based biowaiver approach using biphasic dissolution test. Dissolution Technology, 28( 4), 40-48. doi:10.14227/DT280421P40
NLM
Silva DA, Melo KJC, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. A BCS-based biowaiver approach using biphasic dissolution test [Internet]. Dissolution Technology. 2021 ; 28( 4): 40-48.[citado 2024 out. 04 ] Available from: https://doi.org/10.14227/DT280421P40
Vancouver
Silva DA, Melo KJC, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. A BCS-based biowaiver approach using biphasic dissolution test [Internet]. Dissolution Technology. 2021 ; 28( 4): 40-48.[citado 2024 out. 04 ] Available from: https://doi.org/10.14227/DT280421P40
Artigo de periodico
In vitro therapeutic equivalence of cephalexin 500 mg tablets commercialized in Brazil (2018)
Ghisleni, Daniela Dal Molim ; Kikuchi, Irene Satiko ; Saviano, Alessandro Morais; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar; Araujo, Gabriel Lima Barros de ; Pinto, Terezinha de Jesus Andreoli ; Lourenço, Felipe Rebello
Fonte: Latin American Journal of Pharmacy. Unidade: FCF
Assuntos: BIOEQUIVALÊNCIA, MEDICAMENTO GENÉRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GHISLENI, Daniela Dal Molim et al. In vitro therapeutic equivalence of cephalexin 500 mg tablets commercialized in Brazil. Latin American Journal of Pharmacy, v. 37, n. 1, p. 7-11, 2018Tradução . . Acesso em: 04 out. 2024.
APA
Ghisleni, D. D. M., Kikuchi, I. S., Saviano, A. M., Bou-Chacra, N. A., Löbenberg, R., Araujo, G. L. B. de, et al. (2018). In vitro therapeutic equivalence of cephalexin 500 mg tablets commercialized in Brazil. Latin American Journal of Pharmacy, 37( 1), 7-11.
NLM
Ghisleni DDM, Kikuchi IS, Saviano AM, Bou-Chacra NA, Löbenberg R, Araujo GLB de, Pinto T de JA, Lourenço FR. In vitro therapeutic equivalence of cephalexin 500 mg tablets commercialized in Brazil. Latin American Journal of Pharmacy. 2018 ; 37( 1): 7-11.[citado 2024 out. 04 ]
Vancouver
Ghisleni DDM, Kikuchi IS, Saviano AM, Bou-Chacra NA, Löbenberg R, Araujo GLB de, Pinto T de JA, Lourenço FR. In vitro therapeutic equivalence of cephalexin 500 mg tablets commercialized in Brazil. Latin American Journal of Pharmacy. 2018 ; 37( 1): 7-11.[citado 2024 out. 04 ]
Artigo de periodico
Challenges and opportunities to use biowaivers to compare generics in China (2014)
Zuo, Jieyu; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar
Fonte: AAPS PharmSciTech. Unidade: FCF
Assuntos: BIOEQUIVALÊNCIA, MEDICAMENTO GENÉRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZUO, Jieyu e BOU-CHACRA, Nadia Araci e LÖBENBERG, Raimar. Challenges and opportunities to use biowaivers to compare generics in China. AAPS PharmSciTech, v. 15, n. 5, p. 1070-1075, 2014Tradução . . Disponível em: https://doi.org/10.1208/s12249-014-0133-8. Acesso em: 04 out. 2024.
APA
Zuo, J., Bou-Chacra, N. A., & Löbenberg, R. (2014). Challenges and opportunities to use biowaivers to compare generics in China. AAPS PharmSciTech, 15( 5), 1070-1075. doi:10.1208/s12249-014-0133-8
NLM
Zuo J, Bou-Chacra NA, Löbenberg R. Challenges and opportunities to use biowaivers to compare generics in China [Internet]. AAPS PharmSciTech. 2014 ; 15( 5): 1070-1075.[citado 2024 out. 04 ] Available from: https://doi.org/10.1208/s12249-014-0133-8
Vancouver
Zuo J, Bou-Chacra NA, Löbenberg R. Challenges and opportunities to use biowaivers to compare generics in China [Internet]. AAPS PharmSciTech. 2014 ; 15( 5): 1070-1075.[citado 2024 out. 04 ] Available from: https://doi.org/10.1208/s12249-014-0133-8
Artigo de periodico
Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas (2012)
Löbenberg, Raimar; Bou-Chacra, Nadia Araci ; Stippler, Erika S; Shah, Vinod P; De Stefano, Anthony J; Hauck, Walter W; Williams, Roger L
Fonte: American Association of Pharmaceutical Scientists. Unidade: FCF
Assunto: BIOEQUIVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LÖBENBERG, Raimar et al. Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas. American Association of Pharmaceutical Scientists, v. 14, n. 3, p. 462-472, 2012Tradução . . Disponível em: https://doi.org/10.1208/s12248-012-9350-9. Acesso em: 04 out. 2024.
APA
Löbenberg, R., Bou-Chacra, N. A., Stippler, E. S., Shah, V. P., De Stefano, A. J., Hauck, W. W., & Williams, R. L. (2012). Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas. American Association of Pharmaceutical Scientists, 14( 3), 462-472. doi:10.1208/s12248-012-9350-9
NLM
Löbenberg R, Bou-Chacra NA, Stippler ES, Shah VP, De Stefano AJ, Hauck WW, Williams RL. Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas [Internet]. American Association of Pharmaceutical Scientists. 2012 ; 14( 3): 462-472.[citado 2024 out. 04 ] Available from: https://doi.org/10.1208/s12248-012-9350-9
Vancouver
Löbenberg R, Bou-Chacra NA, Stippler ES, Shah VP, De Stefano AJ, Hauck WW, Williams RL. Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas [Internet]. American Association of Pharmaceutical Scientists. 2012 ; 14( 3): 462-472.[citado 2024 out. 04 ] Available from: https://doi.org/10.1208/s12248-012-9350-9

Unidades USP

ReP

Filtros

Autores

Autores USP